Volume | 475,552 |
|
|||||
News | - | ||||||
Day High | 0.0393 | Low High |
|||||
Day Low | 0.0201 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Avenir Wellness Solutions Inc (QB) | AVRW | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0393 | 0.0201 | 0.0393 | 0.037 | 0.0439 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
24 | 475,552 | US$ 0.029697 | US$ 14,123 | - | 0.0201 - 0.25 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:27:52 | 1,010 | US$ 0.037 | USD |
Avenir Wellness Solutions Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 2.87M | 77.47M | 40.72M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Avenir Wellness Solutions (QB) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVRW Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0331 | 0.045 | 0.0201 | 0.0361977 | 14,155 | 0.0039 | 11.78% |
1 Month | 0.04245 | 0.0555 | 0.0201 | 0.0401034 | 19,117 | -0.00545 | -12.84% |
3 Months | 0.04255 | 0.0555 | 0.0201 | 0.0373555 | 25,616 | -0.00555 | -13.04% |
6 Months | 0.07 | 0.095 | 0.0201 | 0.051829 | 43,280 | -0.033 | -47.14% |
1 Year | 0.11 | 0.25 | 0.0201 | 0.0569944 | 39,641 | -0.073 | -66.36% |
3 Years | 0.11 | 0.25 | 0.0201 | 0.0569944 | 39,641 | -0.073 | -66.36% |
5 Years | 0.11 | 0.25 | 0.0201 | 0.0569944 | 39,641 | -0.073 | -66.36% |
Avenir Wellness Solutions (QB) Description
CURE Pharmaceutical is a broad platform technology company that develops proprietary drug, nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and patient/consumer experience for a wide range of active ingredients. The Company will continue down the path creating new innovative technology that will be part of its incubator strategy. The Sera Labs, Inc. (Sera Labs), a wholly owned subsidiary of CURE, is a trusted leader in the wellness, and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips. The Company sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow their beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery chains, and mass retailers. For more information visit: Seratopicalrevolution.com, Seratopical.com, Seralabshealth.com and follow Sera Labs on Instagram at @seratopical, as well as Twitter and Facebook. |